Agrupación Estratéxica en Xestión e Produción sustentable de Biorrecursos (BioReDes)
Agrupación estratéxica de I+D+i
![Foto de Agrupación Estratéxica en Xestión e Produción sustentable de Biorrecursos (BioReDes)](/img/noimage.png)
![Foto de GlaxoSmithKline (Spain)](/img/noimage_org.png)
GlaxoSmithKline (Spain)
Madrid, EspañaPublicacións en colaboración con investigadores/as de GlaxoSmithKline (Spain) (7)
2010
-
Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959
2005
-
Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972
2003
-
Differences in Co-Resistance to Ciprofloxacin and Penicillin Depending upon the Phenotype of Erythromycin Resistance in Streptococcus pneumoniae
Journal of Chemotherapy, Vol. 15, Núm. 5, pp. 512-514
-
Evolution of penicillin and erythromycin co-resistance in Streptococcus pneumoniae in Spain
International Journal of Antimicrobial Agents, Vol. 22, Núm. 5, pp. 541-544
2002
-
Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain
Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667
-
Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]
Journal of Antimicrobial Chemotherapy
2001
-
Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999
Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 11, pp. 3226-3228